These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15032020)

  • 1. [A case of prostate cancer with invasion to the middle ureter].
    Matsuo T; Hayashida Y; Takehara K; Tsuda S; Furukawa M; Iwasaki S
    Hinyokika Kiyo; 2004 Jan; 50(1):61-3. PubMed ID: 15032020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of prostate capsular invasion by pelvic magnetic resonance imaging and serum level of prostate specific antigen].
    Mikata K; Uemura H; Fujinami K; Ohuchi H; Miyoshi Y; Ohta J; Osada Y; Jinza S; Kubota Y; Hosaka M; Nakatani I; Takebayashi S
    Hinyokika Kiyo; 2001 Jun; 47(6):385-8. PubMed ID: 11496393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic cancer in a young adult: a report of 2 cases].
    Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostatic cancer with cystic formation: a case report].
    Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1996 Dec; 42(12):977-80. PubMed ID: 9013236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
    Yokoyama S; Fukuhara S; Imazu T; Hara T; Yamaguchi S; Adachi S
    Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic adenocarcinoma presenting with metastatic frontal bone involvement and orbital invasion.
    Patel V; Castell FA; Akinwunmi J; Francis I; Chandrasekharan L; Malhotra R
    Orbit; 2010 Aug; 29(4):213-5. PubMed ID: 20812840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of relapsed stage D2 prostate cancer successfully treated with intraarterial chemotherapy].
    Takahashi Y; Shinoda I; Takeuchi T; Nagatani Y; Kobayashi S; Kuriyama M; Kawada Y
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2477-9. PubMed ID: 1719941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Giant prostate carcinoma treated effectively with endocrine therapy: case report].
    Masue N; Hasegawa Y
    Hinyokika Kiyo; 2007 Feb; 53(2):133-5. PubMed ID: 17352166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of prostate cancer with cyst formation].
    Ishida K; Kubota Y; Takada T; Yamada T; Nakano M; Takahashi Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2003 Apr; 49(4):235-7. PubMed ID: 12784721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
    Nemoto K; Tomita Y
    Scand J Urol Nephrol; 2007; 41(6):558-60. PubMed ID: 17853028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer with penile metastasis: a case report].
    Sawada A; Segawa T; Nakanishi S; Kinoshita H; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Nov; 51(11):771-3. PubMed ID: 16363713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
    Soga N; Onishi T; Arima K; Sugimura Y
    Int J Urol; 2007 Mar; 14(3):192-6; discussion 197. PubMed ID: 17430253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report: mucinous carcinoma of prostate].
    Noma M; Mori N; Kobayashi Y; Hara T; Yamaguchi S
    Hinyokika Kiyo; 2003 Oct; 49(10):591-3. PubMed ID: 14655602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen (PSA) may be a poor marker for progression of prostate cancer after treatment with a combination of chemo-hormonal therapies.
    Sartor O
    J La State Med Soc; 2008; 160(2):99-100. PubMed ID: 18681353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.